• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION SMART 120 150, SFA - 6X150MM; SELF EXPANDING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION SMART 120 150, SFA - 6X150MM; SELF EXPANDING STENT Back to Search Results
Model Number N/A
Device Problems Material Frayed (1262); Torn Material (3024)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/25/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(6).A device history record review was performed and showed that these lots of products met all requirements per the applicable manufacturing quality plan.Additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
When the pouch of a 6 x 150 mm sfa (superficial femoral artery) smart stent was opened for use in an endovascular procedure, it was confirmed that the distal tip was frayed already.Therefore, it was not used for the procedure.It was unknown how the procedure completed.The procedure completed successfully.There was no reported patient injury.The product will not be returned for analysis.The patient¿s information was unknown.The target lesion was unknown.The patient¿s vessel level of tortuosity and calcification was unknown.The rate of stenosis was unknown.
 
Manufacturer Narrative
When the pouch of a 6x150mm sfa (superficial femoral artery) smart stent was opened for use in an endovascular procedure, it was confirmed that the distal tip was frayed.Therefore, it was not used for the procedure.It was unknown how the procedure completed.The procedure completed successfully.There was no reported patient injury.The product will not be returned for analysis.The patient¿s information was unknown.The target lesion was unknown.The patient¿s vessel level of tortuosity and calcification was unknown.The rate of stenosis was unknown.The product was not returned for analysis.A device history record (dhr) review of lot 17673399 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿catheter tip frayed/split/torn - during prep¿ could not be confirmed as the device was not returned for analysis.The exact cause could not be determined.It is unknown what factors may have contributed to this issue between manufacture and the customer noting the reported event.Handling factors may have contributed to the reported event as no damage to the packaging was noted.According to the instructions for use, which is not intended as a mitigation, ¿after careful inspection of the pouch looking for damage to the sterile barrier, carefully peel open the pouch and extract the stent delivery system from the tray.Examine the device for any damage.If it is suspected that the sterility or performance of the device has been compromised, the device should not be used.Evaluate the distal end of the catheter to ensure that the stent is contained within the outer sheath.Do not use if the stent is partially deployed.Advance the device over the guidewire through the hemostatic valve and sheath introducer.Note: if resistance is met during delivery system introduction, the system should be withdrawn and another system should be used.¿ neither the dhr nor the information available suggests a design or manufacturing related cause for the reported event; therefore, no corrective/preventive action will be taken at this time.
 
Manufacturer Narrative
When the pouch of a 6x150mm sfa (superficial femoral artery) smart stent was opened for use in an endovascular procedure, it was confirmed that the distal tip was frayed already.Therefore, it was not used for the procedure.It was unknown how the procedure completed.The procedure completed successfully.There was no reported patient injury.The product will not be returned for analysis.The patient¿s information was unknown.The target lesion was unknown.The patient¿s vessel level of tortuosity and calcification was unknown.The rate of stenosis was unknown.The device was a short-term loan; it was not stored in the lab.There was no damage to the packaging.The pouch was still in the inner box when stored.Additional details were requested but were not provided.The product was not returned for analysis.A device history record (dhr) review of lot 17673399 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿catheter tip frayed/split/torn - during prep¿ could not be confirmed as the device was not returned for analysis.The exact cause could not be determined.It is unknown what factors may have contributed to this issue between manufacture and the customer noting the reported event.Handling factors may have contributed to the reported event as no damage to the packaging was noted.According to the instructions for use, which is not intended as a mitigation, ¿after careful inspection of the pouch looking for damage to the sterile barrier, carefully peel open the pouch and extract the stent delivery system from the tray.Examine the device for any damage.If it is suspected that the sterility or performance of the device has been compromised, the device should not be used.Evaluate the distal end of the catheter to ensure that the stent is contained within the outer sheath.Do not use if the stent is partially deployed.Advance the device over the guidewire through the hemostatic valve and sheath introducer.Note: if resistance is met during delivery system introduction, the system should be withdrawn and another system should be used.¿ neither the dhr nor the information available suggests a design or manufacturing related cause for the reported event; therefore, no corrective/preventive action will be taken at this time.(b)(4).
 
Manufacturer Narrative
Additional details were received that the device was short-term loan; it was not stored in the lab.There was no damage to the packaging.The pouch was still in the inner box when stored.Additional details were requested but were not provided.Additional details are pending and will be submitted within 30 days upon receipt.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMART 120 150, SFA - 6X150MM
Type of Device
SELF EXPANDING STENT
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60th ave
miami lakes FL 33014
MX  33014
Manufacturer (Section G)
CORDIS CORPORATION
14201 nw 60th ave,
miami lakes FL 33014
EI   33014
Manufacturer Contact
karla castro
14201 nw 60th ave
miami lakes, FL 33014
MDR Report Key7036207
MDR Text Key93079779
Report Number9616099-2017-01584
Device Sequence Number1
Product Code FGE
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K042969
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup,Followup
Report Date 01/29/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2019
Device Model NumberN/A
Device Catalogue NumberC06150ML
Device Lot Number17673399
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date10/27/2017
Initial Date Manufacturer Received 10/27/2017
Initial Date FDA Received11/15/2017
Supplement Dates Manufacturer Received12/21/2017
12/27/2017
01/24/2018
Supplement Dates FDA Received01/03/2018
01/23/2018
01/29/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/19/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-